Blocknomi
Key Highlights FDA has granted approval for Merck’s Lipfendra (enlicitide), marking the debut of a once-daily oral PCSK9 inhibitor targeting elevated LDL-C Clinical trials demonstrated Lipfendra reduced LDL-C by 60%,…
Related articles
-
Uber (UBER) Stock Slides as €10 Billion Delivery Hero Acquisition Nears Completion
Blocknomi Published 14.07.2026 17:43
-
Shiba Inu (SHIB): 148.7 Billion Tokens Leave Exchanges, Could It Be the First Bullish Signal in Months?
U.Today Published 14.07.2026 10:28
-
BNB Chain’s AWS-Linked Agent Studio Pushes AI Back Into The Crypto Infrastructure Race
NewsBTC Published 13.07.2026 11:35
-
Market Wrap: WD-40 Soars 15% While Tech Giants Intel (INTC) and Micron (MU) Retreat
Blocknomi Published 10.07.2026 12:48
-
Vitalik Buterin unveils Ethereum’s biggest overhaul since The Merge
Crypto.News Published 06.07.2026 15:07
-
Telegram-Linked GRAM Token Jumps 10% on Binance and Hyperliquid Listing
U.Today Published 02.07.2026 13:21
-
StablecoinX (USDE) Unveils Harness Platform to Streamline Stablecoin Operations
Blocknomi Published 02.07.2026 12:43
-
Mantle’s Chainlink CCIP Migration Puts Bridge Risk Back In The Spotlight
Bitcoinist Published 13.07.2026 23:05